Medicines Security InstituteENGAGE MSI
MSI-SIS · Flagship work

Strategic Intelligence System

A decision architecture connecting evidence, indicators, scenarios and response options across all ten domains.

Programme purpose

From research to decision capability

MSI-SIS is designed to give governments, health systems and major institutions a coherent picture of medicines-security exposure. It converts fragmented evidence into structured assessments, early-warning signals and practical decision pathways.

Core workstreams

  • Common medicines-security data model
  • Dependency and vulnerability mapping
  • Warning indicators and thresholds
  • Scenario library and decision protocols
OPEN MS-SIS PLATFORM ↗

Programme status and next steps

Research platform deployed: MS-SIS supports official source monitoring from FDA, MHRA, EMA and Health Canada, alongside evidence records, analyst signals and response-action workflows. Independent operational validation and live user acceptance testing remain pending. No validated MSI country rankings are claimed.

Status updated 22 October 2026.

OPEN PROGRAMME PLANNING WORKSPACE ↗

Next steps

  1. Complete production acceptance testing of source refresh, availability, freshness and failure handling.
  2. Assign analysts and independent reviewers, assess conflicts and confirm responsibilities.
  3. Pilot evidence-linked signals and response actions with participating institutions, then independently review the methods.
  4. Release reviewed intelligence outputs with source provenance, dates, confidence assessments and explicit evidence limits.
READ THE FIRST MSI OUTLOOK →
Institutional participation

Partner with MSI-SIS.

Governments, companies, funders and scholars may commission, support or contribute to this programme.

DISCUSS PARTICIPATION